Skip to main content
Premium Trial:

Request an Annual Quote

Diagnos Teams with Univ. of Queens for Follicular Lymphoma Dx

NEW YORK (GenomeWeb News) – Canadian data extraction specialty company Diagnos will partner with Ontario’s University of Queens to develop a biomarker-based test and a new algorithm to help doctors diagnose follicular lymphoma, the company said today.
 
Under the first phase of the project, the company will work with the University of Queens’ Cancer Research Institute to develop an automated approach for distinguishing follicular lymphoma from benign lymphoid infiltrates using small samples. The company said it plans to increase its accuracy by using morphological analysis along with immunohistochemistry.
 
In the second phase of research, the company will use its data extraction technologies to find protein or nucleic acid biomarkers that can be used to better diagnose and predict treatment for this type of lymphoma.
 
The company said it selected follicular lymphoma because it currently is a difficult subtype to diagnose with accuracy and confidence.
 

The Scan

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.